Advertisement
Medtronic
Subscribe to Medtronic
View Sample

FREE Email Newsletter

Medtronic’s Distributes i-port Advance Injection Port Device for People with Diabetes

February 14, 2014 10:45 am | by Medtronic | News | Comments

Medtronic, Inc. has begun distribution of i-port Advance® as part of a continued focus to provide meaningful therapy management solutions for people with diabetes. i-port Advance can be used for people on insulin injection therapy who want...

Medtronic Launches 'TOTAL Across' Crossing Catheter in Europe

February 13, 2014 11:21 am | by The Associated Press | News | Comments

Aligned with its commitment to provide innovative medical technology for the interventional treatment of peripheral artery disease, Medtronic, Inc. has initiated the European launch of the TOTAL across crossing catheter, which recently... 

Stent wars: Shrinkage concerns resurface in Medtronic/Boston Scientific DES trial

February 3, 2014 2:20 pm | by Mass Device | News | Comments

Medtech giants Medtronic and Boston Scientific took their long-time stent rivalry to new heights in a 1st-of-its-kind head-to-head study of their next-generation drug-eluting stents, with researchers ultimately reporting little difference...

Advertisement

Gagnon Cardiovascular Institute At Morristown Medical Center Implants Newly Approved Device To Replace Failing Aortic Heart Valves

January 24, 2014 4:38 pm | by PR Newswire | News | Comments

The Gagnon Cardiovascular Institute at Morristown Medical Center today became the first hospital in the tri-state area to adopt a new minimally invasive medical device to treat patients with severe aortic stenosis who are too ill or frail...

Medtronic Pacing Systems First to Be Approved for Full Body MRI Scans Without Positioning Restrictions

January 23, 2014 11:10 am | by Medtronic | News | Comments

Medtronic, Inc. has announced that the Medtronic SureScan pacing systems—the first and only pacing systems in the United States that have been approved by the U.S. Food and Drug Administration (FDA) for use with magnetic resonance imaging...

Medtronic CoreValve System Obtains Early FDA Approval on Exceptional Clinical Performance

January 17, 2014 11:17 am | by The Associated Press | News | Comments

Medtronic today announced the U.S. Food and Drug Administration approval of the self-expanding transcatheter CoreValve System for severe aortic stenosis patients who are too ill or frail to have their aortic valves replaced through traditional...

Renal denervation is 'highly unlikely,' says Medtronic study insider

January 16, 2014 6:13 pm | by Mass Device | News | Comments

The future of renal denervation in treatment of hypertension is shaky at best, according to one of the principal investigators involved with Medtronic's disappointing clinical trial. Despite continued optimism from some of medtech's biggest players...

Jury says Medtronic owes Edwards about $390M

January 16, 2014 11:24 am | by The Associated Press | News | Comments

A federal jury ruled Wednesday that medical device maker Medtronic infringed on a patent held by Edwards Lifesciences and ordered Medtronic to pay its competitor about $390 million in damages. Edwards said it will seek a permanent injunction...

Advertisement

Medtronic to Appeal Federal District Court Verdict

January 15, 2014 11:58 am | by Medtronic | News | Comments

A jury in the Federal District Court of Delaware today decided in favor of Edwards Lifesciences, ruling that the Medtronic CoreValve® System infringed on Edward's Cribier patent (US Pat. No. 8,002,825). Medtronic intends to appeal. "While...

Medtronic CEO: Value-based healthcare is the only way to save medtech

January 13, 2014 6:35 pm | by Mass Device | News | Comments

There's been a lot of hand-wringing in medtech as healthcare systems around the world have moved from fee-for-service to value-based healthcare models that reward for outcomes, rather than for specific procedures. But for Medtronic CEO Omar...

St. Jude CEO: Medtronic's renal denervation miss doesn't dampen our spirits

January 13, 2014 5:55 pm | by Mass Device | News | Comments

St. Jude Medical CEO Daniel Starks remains steadfast in his pursuit of renal denervation in treatment of hypertension, despite the high-profile clinical trial flop suffered just last week by rival medtech titan Medtronic. St. Jude will continue with its...

Medtronic's miss muddles the renal denervation landscape

January 13, 2014 7:29 am | by Mass Device | News | Comments

Medtech titan Medtronic (NYSE:MDT) rocked the renal denervation world when it reported earlier this month that it's bellwether Symplicity clinical trial failed to meet efficacy expectations when compared to a sham control arm. Physicians and...

Medtronic Renal Denervation Trial Fails to Meet Primary Efficacy Endpoint

January 9, 2014 11:19 am | by Medtronic | News | Comments

Medtronic, Inc. has announced that its U.S. pivotal trial in renal denervation for treatment-resistant hypertension, SYMPLICITY HTN-3, failed to meet its primary efficacy endpoint. The trial met its primary safety endpoint, and the trial's...

Advertisement

Medtronic Announces Acquisition of TYRX, Developer of Solutions for Surgical Site Infections

January 6, 2014 12:06 pm | by Medtronic | News | Comments

Medtronic, Inc. today announced that it has acquired TYRX, Inc., a privately held, New Jersey-based developer of implantable combination antibiotic drug and implanted medical devices. TYRX's product offerings include the recently FDA cleared...

Medtronic Begins VICTORY AF Trial of Patients with Persistent or Long-Standing Persistent Atrial Fibrillation

January 6, 2014 10:40 am | by Medtronic | News | Comments

Medtronic, Inc. has announced the first patient has been enrolled in the VICTORY AF clinical trial, a prospective, non-randomized, controlled study of patients with persistent or long-standing persistent atrial fibrillation undergoing an ablation...

Medtronic to invest $6M, create 150 jobs in Puerto Rico expansion

December 23, 2013 2:58 pm | by Mass Device | News | Comments

Medtronic is launching a 3-year, $6 million project to boost its footprint on Puerto Rico, in a move that is slated to bring some 150 new jobs to the Caribbean island, according to Gov. Alejandro García Padilla. "Medtronic's expansion...   

St. Jude Medical halts Enlightn IV trial

December 10, 2013 3:30 pm | by Mass Device | News | Comments

St. Jude Medical is calling off the Enlightn IV trial of the next generation of its renal denervation technology, just a few months after it began. The trial of St. Jude's multi-electrode Enlightn device was slated to enroll about 590 patients...

Revisit Your Patent Licensing Practices Now

December 10, 2013 1:58 pm | by Orion Armon, Partner, Cooley LLP | Blogs | Comments

If your company licenses patented technology (in or out), it is time to revisit your licensing practices in light of recent (and anticipated) changes in patent law. In 2007, the U.S. Supreme Court held in MedImmune, Inc. v. Genentech, Inc...

First Human Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker

December 9, 2013 1:36 pm | by The Associated Press | News | Comments

Continuing its leadership in advanced pacing technology and device miniaturization, Medtronic, Inc., today announced the first-in-human implant of the world's smallest pacemaker: the Micra Transcatheter Pacing System. The device was implanted...

Medtronic Presents First-of-Its-Kind Data Showing Sustained Results with Cervical Disc Replacement After Seven Years

December 6, 2013 10:06 am | by The Associated Press | News | Comments

Medtronic, Inc. presented 7-year clinical and radiographic outcomes of artificial disc replacement with PRESTIGE® Cervical Disc compared to anterior cervical discectomy and fusion (ACDF) yesterday at the Cervical Spine Research Society Annual...

Endurant II AAA Stent Graft from Medtronic Delivers Durable, Consistent, and Proven Outcomes in Real-World Setting

November 26, 2013 10:18 am | by Medtronic | News | Comments

Chosen for nearly one out of every two endovascular abdominal aortic aneurysm (AAA) repairs worldwide, the Endurant II AAA stent graft system from Medtronic, Inc. continues to demonstrate long-term durability and consistent outcomes at three...

Appeals court affirms $10M Medtronic loss in catheter patent case

November 19, 2013 11:00 am | by Mass Device | News | Comments

A federal appeals court dealt a blow to Medtronic yesterday when it upheld a lower court's decision to award $10 million to the physician inventor of a patent involving catheters. The U.S. Court of Appeals for the Federal Circuit affirmed an...

Unexpectedly strong ICD sales for Medtronic buoy Boston Scientific

November 19, 2013 9:59 am | by Mass Device | News | Comments

Medtronic posted stronger-than-expected U.S. sales growth for its implantable cardioverter defibrillators, buoying shares of ICD rival Boston Scientific. Medtronic's U.S. ICD sales grew 3.9% during its fiscal 2014 2nd quarter ended Oct. 25, rising...

Trial Shows Significant Delay in Atrial Fibrillation Disease Progression with Medtronic-Exclusive Pacing Features

November 18, 2013 12:09 pm | by Medtronic | News | Comments

New research shows that Medtronic Inc. pacemakers with enhanced pacing features have the ability to slow the progression of atrial fibrillation (AF) in patients with bradycardia, or a slow heartbeat. Presented as a late breaking clinical trial...

FDA Issues Stern Warning on Medtronic Devices

November 16, 2013 7:19 pm | by David Koenig - AP Business Writer | News | Comments

Federal health officials say that defects in some Medtronic devices used in heart procedures are severe enough that they could cause serious injury or death. The warning covers about 15,000 recalled guidewires, which are inserted through an artery...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading